pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,132
stories
27d
BMS clinches pivotal win for myeloma CAR T in ‘key derisking event’
biospace
27d
NodThera, a decade-old NLRP3 player, plans Phase 3 and a rebrand
endpoints
27d
A new immuno-oncology play raises $225M for a next-generation drug
biopharma dive
27d
Caspian launches with $50M, Lilly support to advance disease-modifying diabetes bet
biospace
27d
Kura creates Lilly-backed spinout armed with $50M to advance next-gen diabetes therapy
fiercebiotech
27d
Opinion: Autonomous AI will beat AI-assisted physicians at some medical tasks by 2030
stat
27d
Abbott garners FDA nod for its TactiFlex catheter to treat AFib
fiercebiotech
27d
Beeline flies into phase 3 as oral lupus drug soars past placebo
fiercebiotech
27d
Beyond China: Five other overseas destinations for biopharma dollars
biospace
27d
Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapy
biopharma dive
28d
Inhibrx’s OX40 agonist add-on beats Keytruda alone in head and neck cancer
biospace
28d
STAT+: Health care features prominently in Democrats’ agenda
stat
28d
Roivant's pulmonary hypertension drug shines with ‘blowout’ Phase 2 data
biospace
28d
STAT+: FDA approves AstraZeneca breast cancer drug
stat
28d
AstraZeneca’s SERD pill overcomes adcomm defeat to win FDA nod in breast cancer
biospace
28d
Novartis’ $12B Avidity acquisition hits Phase 3 speedbump as dystrophy drug disappoints
biospace
28d
STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies
stat
28d
An administrative gap delays access to new pancreatic cancer treatment
stat
28d
STAT+: Roivant lung disease drug hits mid-stage study goals
stat
28d
FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancer
fiercebiotech
28d
Pharvaris' latest phase 3 win builds case for HAE drug with FDA verdict pending
fiercebiotech
28d
Bristol Myers’ pivotal CAR-T multiple myeloma trial hits primary endpoint
fiercebiotech
28d
STAT+: UnitedHealth executives shower high-ranking Democrat with donations ahead of midterms
stat
28d
A breakthrough pancreatic cancer drug won approval. They still struggle to access it
stat
28d
Reynolds is selling fruity new vapes unauthorized by FDA
stat
28d
Novartis stock slides as centerpiece of $12B Avidity buyout flunks ‘crucial’ phase 3 test
fiercebiotech
28d
Inhibrx CEO says progression-free survival data leave ‘no question’ about OX40 agonist’s durability
fiercebiotech
28d
Recon: FDA approves AZ’s breast cancer drug over negative adcomm vote; Novartis sees setbacks for drugs targeting cholesterol, m...
raps
29d
FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote
endpoints
29d
STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation
stat
← prev
page 10 of 38
next →
